Intratubular germ cell neoplasia of the testis and its associated cancers: the use of novel biomarkers

References

• Einhorn LH. Curing metastatic testicular cancer. PNAS 2002; 99: 4592–4595.
   PubMed Web of Science ®Google Scholar
• Horwich A, Shipley J, Huddart R. Testicular germ-cell cancer. Lancet 2006; 367: 754–765.
   PubMed Web of Science ®Google Scholar
• Oosterhuis JW, Looijenga LH. Testicular germ-cell tumours in a broader perspective. Nature Rev Cancer 2005; 5: 210–222.
   PubMed Web of Science ®Google Scholar
• Rajpert-De Meyts E, Hoei-Hansen CE. From gonocytes to testicular cancer: the role of impaired gonadal development. Ann NY Acad Sci 2007; 1120: 168–180.
   PubMedGoogle Scholar
• Swerdlow AJ, Huttly SR, Smith PG. Prenatal and familial associations of testicular cancer. Br J Cancer 1987; 55: 571–577.
   PubMed Web of Science ®Google Scholar
• Braun MM, Ahlbom A, Floderus B, Brinton LA, Hoover RN. Effect of twinship on incidence of cancer of the testis, breast, and other sites (Sweden). Cancer Causes Control 1995; 6: 519–524.
   PubMed Web of Science ®Google Scholar
• DePue RH, Pike MC, Henderson BE. Estrogen exposure during gestation and risk of testicular cancer. J Natl Cancer Inst 1983; 71: 1151–1155.
   PubMed Web of Science ®Google Scholar
• Cools M, van Aerde K, Kersemaekers AM, et al Morphological and immunohistochemical differences between gonadal maturation delay and early germ cell neoplasia in patients with undervirilization syndromes. J Clin Endocrinol Metab 2005; 90: 5295–5303.
   PubMed Web of Science ®Google Scholar
• Honecker F, Stoop H, de Krijger RR, Chris Lau YF, Bokemeyer C, Looijenga LH. Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cells. J Pathol 2004; 203: 849–857.
   PubMed Web of Science ®Google Scholar
• Looijenga LHJ. Human testicular (non)seminomatous germ cell tumours: the clinical implications of recent pathobiological insights. J Pathol 2008; 218: 146–162.
   Google Scholar
• Skakkebaek NE. Possible carcinoma-in-situ of the undescended testis. Lancet 1972; 2: 516–517.
   PubMed Web of Science ®Google Scholar
• Ulbright TM, Amin MB, Young RH. Atlas of Tumor Pathology: Tumors of the testis, adenexa, spermatic cord and scrotum. Third series. Washington, DC: Armed Forces Institute of Pathology, 1999.
   Google Scholar
• Skakkebaek NE, Berthelsen JG, Visfeldt J. Clinical aspects of testicular carcinoma-in-situ. Int J Androl 1981; 4 (Suppl): 153–162.
   PubMedGoogle Scholar
• McIntyre A, Gilbert D, Goddard N, et al Genes, chromosomes and the development of testicular germ cell tumors of adolescents and adults. Genes, Chromosomes Cancer 2008; 47: 547–557.
   PubMedGoogle Scholar
• Honecker F, Oosterhuis JW, Mayer F, Hartmann JT, Bokemeyer C, Looijenga LHJ. New insights into the pathology and molecular biology of human germ cell tumors. World J Urol 2004; 22: 15–24.
   PubMedGoogle Scholar
• Rajpert-De Meyts E. Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects. Hum Reprod Update 2006; 12: 303–323.
   PubMed Web of Science ®Google Scholar
• Korkola JE, Houldsworth J, Chadalavada RS, et al Down-regulation of stem cell genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumors. Cancer Res 2006; 66: 820–827.
   PubMed Web of Science ®Google Scholar
• Clark AT, Rodriguez RT, Bodnar MS, et al Human STELLAR, NANOG, and GDF3 genes are expressed in pluripotent cells and map to chromosome 12p13, a hotspot for teratocarcinoma. Stem Cells 2004; 22: 169–179.
   PubMedGoogle Scholar
• Gashaw I, Dushaj O, Behr R, et al Novel germ cell markers characterize testicular seminoma and fetal testis. Mol Hum Reprod 2007; 13: 721–727.
   PubMedGoogle Scholar
• Sperger JM, Chen X, Draper JS, et al Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc Nat Acad Sci USA 2003; 100: 13350–13355.
   PubMed Web of Science ®Google Scholar
• Skotheim RI, Lind GE, Monni O, et al Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development. Cancer Res 2005; 65: 5588–5598.
   PubMed Web of Science ®Google Scholar
• Almstrup K, Leffers H, Lothe RA, et al Improved gene expression signature of testicular carcinoma in situ. Int J Androl 2007; 30: 292–303.
   PubMedGoogle Scholar
• Young RH. Testicular tumors—some new and a few perennial problems. Arch Pathol Lab Med 2008; 132: 548–564.
   PubMed Web of Science ®Google Scholar
• Ulbright TM. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues. Mod Pathol 2005; 18 (Suppl 2):S61–S79.
   Google Scholar
• Emerson RE, Ulbright TM. The use of immunohistochemistry in the differential diagnosis of tumors of the testis and paratestis. Semin Diagn Pathol 2005; 22: 33–50.
   PubMed Web of Science ®Google Scholar
• Emerson RE, Ulbright TM. Morphological approach to tumours of the testis and paratestis. J Clin Pathol 2007; 60: 866–880.
   PubMedGoogle Scholar
• Kristensen DM, Sonne SB, Ottesen AM, et al Origin of pluripotent germ cell tumours: the role of microenvironment during embryonic development. Mol Cell Endocrinol 2008; 288: 111–118.
   PubMedGoogle Scholar
• Cools M, Honecker F, Stoop H, et al Maturation delay of germ cells in fetuses with trisomy 21 results in increased risk for the development of testicular germ cell tumors. Hum Pathol 2006; 37: 101–111.
   PubMedGoogle Scholar
• Looijenga LH, Hersmus R, Oosterhuis JW, Cools M, Drop SL, Wolffenbuttel KP. Tumor risk in disorders of sex development (DSD). Best Pract Res Clin Endocrinol Metab 2007; 21: 480–495.
   PubMed Web of Science ®Google Scholar
• Schumacher V, Gueler B, Looijenga LH, et al Characteristics of testicular dysgenesis syndrome and decreased expression of SRY and SOX9 in Frasier syndrome. Mol Reprod Dev 2008; 75: 1484–1494.
   PubMedGoogle Scholar
• Gopalan A, Dhall D, Olgac S, et al Testicular mixed germ cell tumors: a morphological and immunohistochemical study using stem cell markers, OCT3/4, SOX2, and GDF3, with emphasis on morphologically difficult-to-classify areas. Mod Pathol 2009; 22: 1066–1074.
   PubMedGoogle Scholar
• Ezeh UI, Turek PJ, Reijo RA, Clark AT. Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer 2005; 104: 2255–2265.
   PubMed Web of Science ®Google Scholar
• Cheng L, Sung M-T, Cossu-Rocca P, et al OCT4: biological functions and clinical applications as a marker of germ cell neoplasia. J Pathol 2007; 211: 1–9.
   PubMed Web of Science ®Google Scholar
• Cheng L, Thomas A, Roth LM, Zheng W, Michael H, Karim FW. OCT4: a novel biomarker for dysgerminoma of the ovary. Am J Surg Pathol 2004; 28: 1341–1346.
   PubMedGoogle Scholar
• Terrier-Lacombe MJ, Martinez-Madrigal F, Porta W, Rahal J, Droz JP. Embryonal rhabdomyosarcoma arising in a mature teratoma of the testis: a case report. J Urol 1990; 143: 1232–1234.
   PubMedGoogle Scholar
• Jones TD, Ulbright TM, Eble JN, Cheng L. OCT4: A sensitive and specific biomarker for intratubular germ cell neoplasia of the testis. Clin Cancer Res 2004; 10: 8544–8547.
   PubMedGoogle Scholar
• Jones TD, Ulbright TM, Eble JN, Cheng L. OCT4 staining in testicular tumors: a sensitive and specific marker for seminoma and embryonal carcinoma. Am J Surg Pathol 2004; 28: 935–940.
   Google Scholar
• de JJ, Stoop H, Dohle GR, et al Diagnostic value of OCT3/4 for pre-invasive and invasive testicular germ cell tumours. J Pathol 2005; 206: 242–249.
   PubMedGoogle Scholar
• Browne TJ, Richie JP, Gilligan TD, Rubin MA. Intertubular growth in pure seminomas: associations with poor prognostic parameters. Hum Pathol 2005; 36: 640–645.
   PubMedGoogle Scholar
• Looijenga LH, Stoop H, de Leeuw HP, et al POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res 2003; 63: 2244–2250.
   PubMed Web of Science ®Google Scholar
• Chang MC, Vargas SO, Hornick JL, Hirsch MS, Crum CP, Nucci MR. Embryonic stem cell transcription factors and D2-40 (podoplanin) as diagnostic immunohistochemical markers in ovarian germ cell tumors. Int J Gynecol Pathol 2009; 28: 347–355.
   PubMedGoogle Scholar
• Sotomayor P, Godoy A, Smith GJ, Huss WJ. Oct4A is expressed by a subpopulation of prostate neuroendocrine cells. Prostate 2009; 69: 401–410.
   PubMed Web of Science ®Google Scholar
• Giwercman A, Müller J, Skakkebaek NE. Prevalence of carcinoma in situ and other histopathological abnormalities in testes from 399 men who died suddenly and unexpectedly. J Urol 1991; 145: 77–80.
   PubMedGoogle Scholar
• Jones TD, MacLennan GT, Bonnin JM, Varsegi MF, Blair JE, Cheng L. Screening for intratubular germ cell neoplasia of the testis using OCT4 immunohistochemistry. Am J Surg Pathol 2006; 30: 1427–1431.
   PubMedGoogle Scholar
• Li Y, Tabatabai ZL, Lee TL, et al The Y-encoded TSPY protein: a significant marker potentially plays a role in the pathogenesis of testicular germ cell tumors. Hum Pathol 2007; 38: 1470–1481.
   PubMed Web of Science ®Google Scholar
• Hoei-Hansen CE, Almstrup K, Nielsen JE, et al Stem cell pluripotency factor NANOG is expressed in human fetal gonocytes, testicular carcinoma in situ and germ cell tumours. Histopathology 2005; 47: 48–56.
   PubMed Web of Science ®Google Scholar
• Hart AH, Hartley L, Parker K, et al The pluripotency homeobox gene NANOG is expressed in human germ cell tumors. Cancer 2005; 104: 2092–2098.
   PubMed Web of Science ®Google Scholar
• Siu MK, Wong ES, Chan HY, Ngan HY, Chan KY, Cheung AN. Overexpression of NANOG in gestational trophoblastic diseases: effect on apoptosis, cell invasion, and clinical outcome. Am J Pathol 2008; 173: 1165–1172.
   PubMed Web of Science ®Google Scholar
• Cao D, Humphrey PA, Allan R. SALL4 is a novel sensitive and specific marker for metastatic germ cell tumors, with particular utility in detection of metastatic yolk sac tumors. Cancer 2009; 115: 2640–2651.
   Google Scholar
• Pan G, Thompson JA. Nanog and transcriptional networks in embryonic stem cell pluripotency. Cell Research 2007; 17: 42–49.
   PubMed Web of Science ®Google Scholar
• Biermann K, Heukamp LC, Steger K, et al Genome-wide expression profiling reveals new insights into pathogenesis and progression of testicular germ cell tumors. Cancer Genomics Proteomics 2007; 4: 359–367.
   PubMedGoogle Scholar
• Santagata S, Ligon KL, Hornick JL. Embryonic stem cell transcription factor signatures in the diagnosis of primary and metastatic germ cell tumors. Am J Surg Pathol 2007; 31: 836–845.
   PubMed Web of Science ®Google Scholar
• de Jong J, Stoop H, Gillis AJ, et al Differential expression of SOX17 and SOX2 in germ cells and stem cells has biological and clinical implications. J Pathol 2008; 215: 21–30.
   PubMed Web of Science ®Google Scholar
• Berney DM, Shamash J, Pieroni K, Oliver RT. Loss of CD30 expression in metastatic embryonal carcinoma: the effects of chemotherapy? Histopathology 2001; 39: 382–385.
   PubMed Web of Science ®Google Scholar
• Zeeman AM, Stoop H, Boter M, et al VASA is a specific marker for both normal and malignant human germ cells. Lab Invest 2002; 82: 159–166.
   PubMedGoogle Scholar
• Datta MW, Macri E, Signoretti S, Renshaw AA, Loda M. Transition from in situ to invasive testicular germ cell neoplasia is associated with the loss of p21 and gain of mdm-2 expression. Mod Pathol 2001; 14: 437–442.
   PubMedGoogle Scholar
• Moore BE, Banner BF, Gokden M, et al p53: a good diagnostic marker for intratubular germ cell neoplasia, unclassified. Appl Immunohistochem Mol Morphol 2001; 9: 203–206.
   PubMedGoogle Scholar
• Bartkova J, Bartek J, Lukas J, et al p53 protein alterations in human testicular cancer including pre-invasive intratubular germ-cell neoplasia. Int J Cancer 1991; 49: 196–202.
   PubMedGoogle Scholar
• Fombonne J, Devouassoux-Shisheboran M, Bouvier R, Droz J-P, Benahmed M, Krantic S. Analysis of p16INK4A gene promoter in male germ-cell tumors: identification of a new point mutation. Cancer Detect Prev 2004; 29: 1–7.
   PubMedGoogle Scholar
• Tsoumpou I, Arbyn M, Kyrgiou M, et al p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis. Cancer Treat Rev 2009; 35: 210–220.
   PubMed Web of Science ®Google Scholar
• Manivel JC, Jessurun J, Wick MR, Dehner LP. Placental alkaline phosphatase immunoreactivity in testicular germ cell tumors. Am J Surg Pathol 1987; 11: 21–29.
   PubMed Web of Science ®Google Scholar
• Hustin J, Collettee J, Franchimont P. Immunohistochemical demonstration of placental alkaline phosphatase in various states of testicular development and in germ cell tumours. Int J Androl 1987; 10: 29–35.
   PubMedGoogle Scholar
• Berney DM, Lee A, Randle SJ, Jordan S, Shamash J, Oliver RT. The frequency of intratubular embryonal carcinoma: implications for the pathogenesis of germ cell tumours. Histopathology 2004; 45: 155–161.
   PubMedGoogle Scholar
• Lau SK, Weiss LM, Chu PG. D2-40 immunohistochemistry in the differential diagnosis of seminoma and embryonal carcinoma: a comparative immunohistochemical study with KIT (CD117) and CD30. Mod Pathol 2007; 20: 320–325.
   PubMed Web of Science ®Google Scholar
• Hittmair A, Rogatsch H, Hobisch A, Mikuz G, Feichtinger H. CD30 expression in seminoma. Hum Pathol 1996; 27: 1166–1171.
   PubMed Web of Science ®Google Scholar
• Biermann K, Göke F, Nettersheim D, et al c-KIT is frequently mutated in bilateral germ cell tumours and down-regulated during progression from intratubular germ cell neoplasia to seminoma. J Pathol 2007; 213: 311–318.
   PubMed Web of Science ®Google Scholar
• Stoop H, Honecker F, van de Geijn GJM, et al Stem cell factor as a novel diagnostic marker for early malignant germ cells. J Pathol 2008; 216: 43–54.
   PubMed Web of Science ®Google Scholar
• Biermann K, Heukamp LC, Steger K, et al Gene expression profiling identifies new biological markers of neoplastic germ cells. Anticancer Res 2007; 27: 3091–3100.
   PubMed Web of Science ®Google Scholar
• Goddard NC, McIntyre A, Summersgill B, Gilbert D, Kitazawa S, Shipley J. KIT and RAS signalling pathways in testicular germ cell tumours: new data and a review of the literature. Int J Androl 2007; 30: 337–348.
   PubMedGoogle Scholar
• Zynger DL, Dimov ND, Luan C, Teh BT, Yang XJ. Glypican 3: a novel marker in testicular germ cell tumors. Am J Surg Pathol 2006; 30: 1570–1575.
   PubMed Web of Science ®Google Scholar
• Kandil DH, Cooper K. Glypican-3: a novel diagnostic marker for hepatocellular carcinoma and more. Adv Anat Pathol 2009; 16: 125–129.
   PubMed Web of Science ®Google Scholar
• Ota S, Hishinuma M, Yamauchi N, et al Oncofetal protein glypican-3 in testicular germ-cell tumor. Virchows Arch 2006; 449: 308–314.
   PubMedGoogle Scholar
• Sonne SB, Herlihy AS, Hoei-Hansen CE, et al Identity of M2A (D2-40) antigen and gp36 (Aggrus, T1A-2, podoplanin) in human developing testis, testicular carcinoma in situ and germ-cell tumours. Virchows Arch 2006; 449: 200–206.
   PubMed Web of Science ®Google Scholar
• Lifschitz-Mercer B, Elliott DJ, Leider-Trejo L, et al Absence of RBM expression as a marker of intratubular (in situ) germ cell neoplasia of the testis. Hum Pathol 2000; 31: 1116–1120.
   PubMedGoogle Scholar
• Batistatou A, Scopa. C.D., Ravazoula P, et al Involvement of dysadherin and E-cadherin in the development of testicular tumors. Br J Cancer 2005; 93: 1382–1387.
   PubMedGoogle Scholar
• Honecker F, Kersemaekers A-MF, Molier M, et al Involvement of E-cadherin and β-catenin in germ cell tumours and in normal male fetal germ cell development. J Pathol 2004; 204: 167–174.
   PubMedGoogle Scholar
• Dimov ND, Zynger DL, Luan C, Kozlowski JM, Yang XJ. Topoisomerase II alpha expression in testicular germ cell tumors. Urology 2007; 69: 955–961.
   PubMedGoogle Scholar
• Honecker F, Wermann H, Mayer F, et al Microsatelite instability, mismatch repair deficiency, and BRAF mutation in treatment-resistant germ cell tumors. J Clin Oncol 2009; 27: 2129–2136.
   PubMed Web of Science ®Google Scholar
• Velasco A, Corvalan A, Wistuba II, et al Mismatch repair expressio in testicular ceance predicts recurrence and survival. Int J Cancer 2008; 122: 1774–1777.
   PubMed Web of Science ®Google Scholar
• Bing Z, Pasha T, Tomaszewski JE, Zhang P. CDX2 expression in yolk sac component of testicular germ cell tumors. Int J Surg Pathol 2009; 17: 373–377.
   PubMedGoogle Scholar
• Rago V, Romeo F, Giordano F, Ferraro A, Ando S, Carpino A. Identification of ERbeta1 and ERbeta2 in human seminoma, in embryonal carcinoma and in their adjacent intratubular germ cell neoplasia. Reprod Biol Endocrinol 2009; 7: 56.
   PubMedGoogle Scholar
• Mandoky L, Geczi L, Bodrogi I, et al Clinical relevance of HER-2/neu expression in germ-cell testicular tumors. Anticancer Res 2004; 24: 2219–2224.
   PubMedGoogle Scholar
• Soule S, Baldridge L, Kirkpatrick K, et al HER-2/neu expression in germ cell tumours. J Clin Pathol 2002; 55: 656–658.
   PubMed Web of Science ®Google Scholar
• Wang X, Zhang S, MacLennan GT, et al Epidermal growth factor receptor protein expression and gene amplification in the chemorefractory metastatic embryonal carcinoma. Mod Pathol 2009; 22: 7–12.
   PubMed Web of Science ®Google Scholar
• Berney DM, Lee A, Shamash J, et al The association between intratubular seminoma and invasive germ cell tumors. Hum Pathol 2006; 37: 458–461.
   PubMedGoogle Scholar
• Lau SK, Weiss LM, Chu PG. Association of intratubular seminoma and intratubular embryonal carcinoma with invasive testicular germ cell tumors. Am J Surg Pathol 2007; 31: 1045–1049.
   PubMedGoogle Scholar
• Rakheja D, Hoang MP, Sharma S, Albores-Saavedra J. Intratubular embryonal carcinoma: a report of 2 cases. Arch Pathol Lab Med 2002; 126: 487–490.
   PubMedGoogle Scholar
• Berney DM, Lee A, Shamash J, et al The frequency and distribution of intratubular trophoblast in association with germ cell tumors of the testis. Am J Surg Pathol 2005; 29: 1300–1303.
   PubMedGoogle Scholar
• van Casteren NJ, Boellaard WP, Dohle GR, et al Heterogeneous distribution of ITGCNU in an adult testis: consequences for biopsy-based diagnosis. Int J Surg Pathol 2008; 16: 21–24.
   PubMedGoogle Scholar
• van Casteren NJ, Stoop H, Dohle GR, de Wit R, Oosterhuis JW, Looij enga LHJ. Noninvasive detection of testicular carcinoma in situ in semen using OCT3/4. Eur Urol 2008; 54: 153–160.
   PubMedGoogle Scholar
• Cheng L. Establishing a germ cell origin for metastatic tumors using OCT4 immunohistochemistry. Cancer 2004; 101: 2006–2010.
   PubMed Web of Science ®Google Scholar
• Steiner H, Gozzi C, Verdorfer I, Mikuz G, Bartsch G, Hobisch A. Metastatic spermatocytic seminoma—an extremely rare disease. Eur Urol 2006; 49: 183–186.
   PubMedGoogle Scholar
• Matoska J, Ondrus D, Hornäk M. Metastatic spermatocytic seminoma. A case report with light microscopic, ultrastructural, and immunohistochemical findings. Cancer 1988; 62: 1197–1201.
   PubMedGoogle Scholar
• Sung MT, Jones TD, Beck SD, Foster RS, Cheng L. OCT4 is superior to CD30 in the diagnosis of metastatic embryonal carcinomas after chemotherapy. Hum Pathol 2006; 37: 662–667.
   PubMed Web of Science ®Google Scholar
• Leroy X, Augusto D, Leteurtre E, Gosselin B. CD30 and CD117 (c-kit) used in combination are useful for distinguishing embryonal carcinoma from seminoma. J Histochem Cytochem 2002; 50: 283–285.
   PubMed Web of Science ®Google Scholar
• Cui W, Kong NR, Ma Y, Amin HM, Lai R, Chai L. Differential expression of the lovel oncogene, SALL4, in lymphoma, plasma cell myeloma, and acute lymphoblastic leukemia. Mod Pathol 2006; 19: 1585–1592.
   PubMed Web of Science ®Google Scholar